SciRhom
Pre-clinicalSciRhom GmbH is a pioneering biotech enterprise with the vision to translate advanced scientific findings into game-changing therapies for autoimmune diseases. Building on a detailed understanding of how a major cell-surface protease controls inflammation, SciRhom has worked closely with Prof. Carl Blobel of the Hospital for Special Surgery in New York City (USA) to develop first-in-class humanized antibodies against iRhom2. iRhom2 controls the enzyme TACE, a key node in several disease-causi...
Private Company
Total funding raised: $30.5M
About
SciRhom GmbH is a pioneering biotech enterprise with the vision to translate advanced scientific findings into game-changing therapies for autoimmune diseases. Building on a detailed understanding of how a major cell-surface protease controls inflammation, SciRhom has worked closely with Prof. Carl Blobel of the Hospital for Special Surgery in New York City (USA) to develop first-in-class humanized antibodies against iRhom2. iRhom2 controls the enzyme TACE, a key node in several disease-causi...